AbstractThe six-minute walk test (6MWT) highly correlates with results of bicycle ergometry and treadmill as it is used for evaluation of physical activity in patients with chronic heart failure (CHF). In this article performance of the work done and capacity at 6MWT were evaluated in patients with heart failure caused by hypertension with signs of metabolic syndrome. Patients of the studied groups, despite the smaller distance walked, performed significantly (p<0.05) more work with more capacity compared to the control group. Lower results of distance walked during 6MWT were typical for patients with higher FC CHF. With the growth of FC CHF performance and capacity indicators were significantly lower, and the difference was significant between contiguous functional classes, unlike the covered distance. The capacity and performance indicators defined during six-minute walk test in patients with metabolic syndrome signs are more sensitive for the diagnosis of cretain FC in the treatment of heart failure compared to the isolated determination of walked distance.
Amosova E.N., Shpak Ya.V. Systolic and diastolic heart failure: an attempt to conduct comparative analysis of the clinical characteristics, left heart remodeling and treatment quality. Ukraiinskyi terapevtychnyi zhurnal. 2005; 4: 4 – 9.
Belenkov Yu.N., Mareyev YuV., Ageyev F.T. Chronic heart failure. Moscow. HEOTAR-Media. 2006; 432.
Horbas I.M, Voronkov L.H. Epidemiological aspects of chronic heart failure in the adult population of Ukraine. Ukraiinskyi kardiolohichnyi zhurnal. 2008; 4: 8–12.
Gurevych M.A. Chronic heart failure. Moscow. Prakticheskaya meditsina. 2008; 414.
Mitchenko E.I., The importance of the metabolic syndrome in the prevention of acute cardiovascular events: an exaggeration or underestimation of the obvious risk. Ukraiinskyi kardiolohichnyi zhurnal. 2009; appendix 1; 185–191.
Perepech N.B., Kutuzov A.E., Nedoshivin A.O. The use of the six-minute walk test to assess the condition of patients with chronic heart failure. Klinicheskaya meditsina. 2005; 11: 11–16.
Kravchun P.G., Harpryt Sing Hyra, Lapshina L.A. [et al.] Modern approaches to the treatment of patients with metabolic syndrome in cases of chronic heart failure. Ukraiinskyi medychnyi almanakh. 2005; 8(4): 77–82.
Voronkov L.H., Parashcheniuk L.P., Yanovskyi H.V. [et al.] State of the quality of life of patients with chronic heart failure based on basic demographic, clinical and instrumental studies. Krovoobih ta hemostaz. 2008; 3: 52–56.
Tkachenko O.V., Seryk S.A. The results of six-minute walk test in patients with heart failure caused by ischemic heart disease. Ukraiinskyi terapevtychnyi zhurnal. 2005; 4: 14–19.
Chernavskyi S.V., Metabolic syndrome: prognosis of variants of cardiocerebral complications course and development. Mizhnarodnyi endokrynolohichnyi zhurnal. 2012; 1 (41): 21–29.
Shelest A.N., Harpryt Sing Hyra, Salekh S. Kh. Pathogenetic features of chronic heart failure in patients with the metabolic syndrome X: aspects of treatment. Vrachebnaya praktika. 2005; 4: 19–25.
Bautmans I., Lambert M., Mets T. The six-minute walk test in community dwelling elderly: influence of health status. Available from: http://creativecjmmjns.org/licens/by/2.0.
Galinier M., Pathak A., Roncalli J. [et al.] Obesity and cardiac failure. Arch. Mal. Coer. Vaiss. 2005; 98: 39–45.
Miura Y., Fukomoto Y., Shiba N. [et al.] Prevalence and Clinical Implication of Metabolic Syndrome in Chronic Heart Failure. Circ. J. – 2010; 74 (12): 2612–2621.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.